Lance Heilbrun Selected Research

Lance Heilbrun Research Topics

Disease

7	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2012
5	Neoplasms (Cancer) 01/2019 - 08/2012
2	Neutropenia 01/2018 - 12/2015
2	Neoplasm Metastasis (Metastasis) 04/2013 - 01/2012
1	Hyperglycemia 01/2018
1	7 Hereditary Prostate Cancer 01/2018
1	Thrombocytopenia (Thrombopenia) 12/2015
1	Squamous Cell Carcinoma of Head and Neck 04/2015
1	Disease Progression 04/2015
1	Triple Negative Breast Neoplasms 01/2015
1	Colorectal Neoplasms (Colorectal Cancer) 08/2012
1	Adenocarcinoma 08/2012
1	Carcinogenesis 08/2012
1	Kidney Neoplasms (Kidney Cancer) 08/2009
1	Chronic Renal Insufficiency 08/2009
1	Renal Insufficiency (Renal Failure) 08/2009
1	Kidney Diseases (Kidney Disease) 08/2009

Drug/Important Bio-Agent (IBA)

3	Docetaxel (Taxotere)FDA Link 01/2019 - 12/2015
3	Prostate-Specific Antigen (Semenogelase)IBA 01/2019 - 04/2013
3	Prednisone (Sone)FDA LinkGeneric 01/2019 - 12/2015
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2018
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2015 - 08/2012
2	Proteins (Proteins, Gene)FDA Link 01/2015 - 04/2013
2	AndrogensIBA 01/2012 - 01/2012
1	Angiogenesis InhibitorsIBA 01/2019
1	cediranib (AZD2171)IBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Biological ProductsIBA 01/2019
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2019
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	pasireotideIBA 01/2018
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 12/2015
1	Everolimus FDA Link 12/2015
1	Gemcitabine FDA Link 04/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2015
1	Complementary DNA (cDNA)IBA 01/2015
1	veliparibIBA 01/2015
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2015
1	Chymotrypsin FDA Link 04/2013
1	Serine Proteases (Serine Protease)IBA 04/2013
1	EnzymesIBA 04/2013
1	Galectin 3 (LGALS3)IBA 04/2013
1	Celecoxib (Celebrex)FDA Link 08/2012
1	Formaldehyde (Formol)FDA Link 08/2012
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2012
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2012
1	ParaffinIBA 08/2012
1	Capecitabine (Xeloda)FDA Link 08/2012
1	Bevacizumab (Avastin)FDA Link 01/2012
1	Androgen Receptors (Androgen Receptor)IBA 01/2012
1	CreatinineIBA 08/2009
1	Sorafenib (BAY 43-9006)FDA Link 08/2009
1	raf KinasesIBA 08/2009

Therapy/Procedure

4	Therapeutics 01/2018 - 08/2009
3	Drug Therapy (Chemotherapy) 01/2019 - 08/2012
1	Castration 12/2015